Mechanism of a arsenic-mediated cancer development
Mechanism of a arsenic-mediated cancer development
批准号:
16310037
负责人:
KATO Masashi
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
More than ten million people in the world suffered drinking water with high concentration of arsenic (>5 mg/1). It is reported that a risk of cancer development in skin, lung, liver or bladder increases in human in epidemiological research. These reports suggest that arsenic is a carcinogen in the human. To prevent against an explosive increase of cancer in the people who drink arsenic-polluted water, we need to clarify the mechanism of arsenic-induced cancer for establishing effective therapies.The c-RET proto-oncogene encodes a receptor type tyrosine. Ligand of c-RET is glial cell line-derived neurotrophic factor (GDNF), and its signaling is essential for renal organogenesis and enteric neurogenesis. The Ret kinase is activated by point mutations or gene rearrangement. Germ line mutations of the c-RET proto-oncogene are associated with the development of multiple endocrine neoplasia type 2A (MEN2A). Enhancement of oncogenic RET activity through autophosphorylation of tyrosine 905 and tyrosine 1062 are crucially important for transformation.In this study, we clarified mechanism of arsenic-mediated cancer development through analysis of RET tyrosine kinase activation.1) Arsenic-mediated superactivation of RET-MEN2A tyrosine kinase.Arsenic promotes c-RET proto-oncogene product activity (c-RET protein tyrosine kinase). Arsenic superactivates kinase activity of RET oncogene product (RET-MEN2A: c-RET with cysteine 634 replaced arginine), in which kinase activity was 3-10 fold augmented by genetic mutation.2) Arsenic promoted autophosphorylation of key tyrosines for activation in c-RET.Autophosphorylation of tyrosines 905 and 1062 were reported to be crucially important for c-RET kinase activation. Arsenic promoted autophosphorylation of 905 and 1062 tyrosines in c-RET.3) Effect of SOD1 (superoxide dismutase 1) on arsenic-mediated RET kinase activation.We showed that SOD1 inhibited UV-mediated but not arsenic-mediated RET tyrosine kinase activity.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
A PKC-mediated backup mechanism of the MXXCW motif-linked switch for initiating tyrosine kinase activities.
用于启动酪氨酸激酶活性的 MXXCW 基序连接开关的 PKC 介导的备份机制。
DOI:
--
发表时间:
2006
期刊:
FEBS letter 580
影响因子:
--
作者:
[Takeda, K. et al.]
通讯作者:
K. et al.
Molecular Mechanism of Iron Sensing by HapX, the Master Regulator of Iron Homeostasis in Filamentous Fungi
-
批准号:19K05802
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2019
-
负责人:KATO Masashi
-
依托单位:
Molecular mechanisms of transcriptional activation and repression by the major transcription factor of iron homeostasis in filamentous fungi
-
批准号:16K07679
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2016
-
负责人:KATO Masashi
-
依托单位:
Elucidation of effects of point defects on electrical properties of 4H-SiC and development of nrocesses for carrier lifetime control
-
批准号:23760012
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2011
-
负责人:KATO Masashi
-
依托单位:
Iron homeostasis regulated by the CCAAT-binding complex in filamentous fungi.
-
批准号:22580080
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2010
-
负责人:KATO Masashi
-
依托单位:
Analysis of arsenic-mediated carcinogenesis and development of a preventive therapy targeting modulation for three-dimensional structure of oncogene products.
-
批准号:20406003
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.49万
-
财政年份:2008
-
负责人:KATO Masashi
-
依托单位:
An Overview image of the transcription network regulated by the CCAAT binding complex in Aspergillus oryzae
-
批准号:19580088
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2007
-
负责人:KATO Masashi
-
依托单位:
Identification of defects degrading SiC device performance by the excess carrier lifetime mapping with micrometer resolution
-
批准号:19760215
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.45万
-
财政年份:2007
-
负责人:KATO Masashi
-
依托单位:
Assembly and sorting mechanisms of CCAAT-box binding complex of filamentous fungi
-
批准号:16580057
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2004
-
负责人:KATO Masashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于机器学习与分子模拟的新型靶向RET激酶抑制剂筛选与抗肿瘤活性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:左柯
-
依托单位:
基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
-
批准号:2025JJ80476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余一知
-
依托单位:
克服突变耐药的新型RET抑制剂的设计、合成及抗肿瘤活性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:彭丽洁
-
依托单位:
甘草酚通过肠胶质细胞GDNF/RET途径促进ZO-1与肠上皮细胞膜融合保护肠粘膜机械屏障的作用与机制研究
-
批准号:82304147
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:路上云
-
依托单位:
RET基因M918T突变通过JAK/STAT3信号通路轴调控腱糖蛋白C表达促进甲状腺髓样癌细胞干性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:史潇
-
依托单位:
RET-M918T突变通过调控Tenascin C-EGFR复合体形成促进甲状腺髓样癌干性和侵袭转移的机制研究
-
批准号:82373008
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:史潇
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
SPP1+巨噬细胞促肺癌细胞MET活化介导RET抑制剂耐药的机制研究
-
批准号:82303643
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:鲁畅
-
依托单位:
近视视觉信息通过N-retinylidene-PE(N-ret-PE)通路促进视杆光感受器视紫红质再生参与近视
-
批准号:82271121
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2022
-
负责人:支知娜
-
依托单位:
GDNF-RET介导电针调节神经-结肠上皮对话缓解PI-IBS模型小鼠内脏高敏感的机制研究
-
批准号:82274630
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:孙建华
-
依托单位: